Skip to main content
Premium Trial:

Request an Annual Quote

EMBL’s European Bioinformatics Institute, NanoString Technologies, Febit, Prognosys Biosciences

The European Molecular Biology Laboratory’s European Bioinformatics Institute said recently that its ArrayExpress database has doubled in size to contain transcriptomics data from 100,000 hybridizations.
The database now holds snapshots of gene-expression signatures for more than 180 species taken under thousands of experimental conditions. According to EMBL-EBI, the latest data increase reflects the mass import of data from the Gene Expression Omnibus database.

NanoString Technologies this week launched an early-access program for its nCounter Analysis System for digital gene expression. CalTech was its first customer.
The nCounter uses molecular barcodes and single-molecule imaging to detect and count hundreds of unique transcripts in a single reaction. According to NanoString, it is ideally suited for researchers with small amounts of starting material, customers who would like to study defined gene sets, and microarray users seeking to validate expression signatures.

Febit and Prognosys Biosciences this week officially launched their Genome-to-Array Service that enables users studying microbial organisms to go from biological genetic material to a working microarray experiment in weeks.
La Jolla, Calif.-based Prognosys Biosciences will sequence the DNA using an Illumina Genome Analyzer, while Febit will synthesize arrays using its Geniom microarray technology, the companies said.
Febit and Prognosys previously discussed the service with BioArray News in September (see BAN 9/25/2007).

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.